Associated Papers
Is CABP2-Associated Hearing Loss (DFNB93) a Gene Therapy Target? Preclinical Progress and Patient Registry.
Vona B et al.
Medcomm, 2025
Autosomal recessive nonsyndromic hearing impairment in two Finnish families due to the population enriched CABP2 c.637+1G>T variant.
Bharadwaj T et al.
Molecular Genetics & Genomic Medicine, 2022
First reported CABP2-related non-syndromic hearing loss in Northern Europe.
Sheyanth IN et al.
Molecular Genetics & Genomic Medicine, 2021
A Novel Pathogenic Variant in the CABP2 Gene Causes Severe Nonsyndromic Hearing Loss in a Consanguineous Iranian Family.
Koohiyan M et al.
Audiology & Neuro-otology, 2019
Select a paper to view details